ALPG

ALPG

ALPG 분자 정보

Molecule Name
Alkaline phosphatase
분자 별명
ALPG,GCAP,ALP-1,ALPPL2,PLAP-like,ALPPL,Alkaline phosphatase, germ cell type
Drug Development Progress
임상 약물 수3
시판 약물 수1
최고 연구 개발 단계Approved
표적 별명
Alkaline Phosphatase
분자 배경
ALPPL2 is specifically highly expressed in naïve pluripotent stem cells. Moreover, in naïve state somatic cell reprogramming, naïve-primed transformation and other systems, the use of the ALPPL2 promoter-driven fluorescent reporter system can specifically indicate the establishment or withdrawal of naïve state pluripotency, thereby identifying ALPPL2 as naïve state pluripotent. specific cell surface markers. Some studies have found that knockout of ALPPL2 can specifically affect the establishment, stability and maintenance of naïve state pluripotency, proving that ALPPL2 protein is a functional naïve state surface molecular marker.

ALPG 제품 목록

Species
  • Human(2)
  • Mouse(1)
Tag
  • His Tag(2)
  • His Tag & Avi Tag(1)
Host
  • HEK293(3)
Conjugate
  • Unconjugated(2)
  • Biotin-labeled(1)
Grade
  • RUO(3)
Low Endotoxin
  • Yes(1)
  • No(2)
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
ALPG
Human ALPG / ALPPL2 Protein, His Tag, low endotoxin (active enzyme, MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISAEnzyme

$470.00

100ug
ALPG
Avitag
ALG-H52E1
Biotinylated Human ALPG / ALPPL2 Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
ALPG
Mouse ALPG / ALPPL2 Protein, His Tag (active enzyme, MALS verified)
Mouse
HEK293
MALSSDS-PAGE
Enzyme

$410.00

100ug
You Have Viewed 1-3 Of 3 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

항체 프로젝트 거래 플랫폼

프로젝트 이름프로젝트 단계분자 유형분자 출처질병 영역적응증
ALPP/ALPPL2 mAb - 01PCCMonoclonalHumanized MouseSolid TumorEndometrial cancer,Ovarian cancer
프로젝트 이름
ALPP/ALPPL2 mAb - 01
프로젝트 단계
PCC
분자 유형
Monoclonal
분자 출처
Humanized Mouse
질병 영역
Solid Tumor
적응증
Endometrial cancer,Ovarian cancer
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
ALXN-1850ALXN-1850Phase 3 ClinicalAlexion Pharmaceuticals Inc
Hypophosphatasia
상세
Amifostine for nasoduodenal delivery (Xerient Pharma)XER-001Phase 2 ClinicalXerient Pharma
Pancreatic Neoplasms
상세
placenta-derived protein (Zoltan)PALPClinicalZoltan Laboratories
Cachexia; Diabetes Mellitus; Obesity
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
AmifostineWR-2721C; NSC-296961; YM-08310; S-8744; SAPEP; WR-2721ApprovedMedimmune LlcEthyol, 天地达, 安福定Mainland ChinaCytoprotective adjuvantChina Grand Automotive Services Group Co Ltd1995-12-08
Acute Radiation Syndrome; Bone Marrow Diseases; Breast Neoplasms; Carcinoma; Cytoprotective adjuvant; Fanconi Anemia; Gestational Trophoblastic Disease; Head and Neck Neoplasms; Hodgkin Disease; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mucositis; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Nasopharyngeal Neoplasms; Neurotoxicity Syndromes; Neutropenia; Ovarian Neoplasms; Peripheral Nervous System Diseases; Prostatic Neoplasms; Salivary Gland Diseases; Sarcoma; Solid tumours; Trigeminal Neuralgia
상세
Customer Reviews